Acquiring Company
Aurobindo Pharma
Acquired Company
Lannett Company
Hyderabad
PennsylvaniaBiotechnologyPharmaceuticalManufacturingBiotechnologyDescription
Aurobindo Pharma is set to finalize its acquisition of Lannett Company after receiving regulatory approval from the US FTC. The deal aims to strengthen Aurobindo's presence in the American market, following a definitive agreement made in July 2025 for a full buyout. The acquisition is expected to close by the end of June, pending administrative formalities.
Don't miss Aurobindo Pharma's next move
Get an email the moment Aurobindo Pharma makes an acquisition, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
M&A Insights
Based on deal dataFrequently asked
Who acquired Lannett Company?
Lannett Company was acquired by Aurobindo Pharma, based in Hyderabad. The deal was reported on June 19, 2026. Aurobindo Pharma is a Hyderabad-based pharmaceutical company with its US subsidiary, Aurobindo Pharma USA Inc. Aurobindo Pharma is privately held and operates in Biotechnology.
When did Aurobindo Pharma acquire Lannett Company?
Aurobindo Pharma's acquisition of Lannett Company was reported on June 19, 2026. Aurobindo Pharma is set to finalize its acquisition of Lannett Company after receiving regulatory approval from the US FTC. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Lannett Company do?
Lannett Company is a U.S.-based manufacturer and supplier of complex generic pharmaceuticals, including DEA-controlled substances. It is privately held, operating in Manufacturing, and is based in Pennsylvania.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.